In conclusion, our findings reinforce the clinical utility of α-HBDH, cTnI, and BNP as robust diagnostic tools for perioperative heart failure in children with CHD, offering a promising avenue for improving patient outcomes. This evidence concerns the gene TNNI3 and coronary artery disorder.